Overexpression of mdr1-type P-glycoproteins (P-gps) is thought to contribute to primary chemotherapy resistance of untreated hepatocellular carcinoma. However, mechanisms of endogenous multidrug resistance 1 (mdr1) gene activation still remain unclear. Because recent studies have demonstrated overexpression of cyclooxygenase-2 (COX-2) in hepatocytes during early stages of hepatocarcinogenesis, we investigated whether the COX system, which catalyzes the rate-limiting step in prostaglandin synthesis, participates in mdr1 gene regulation. In the present study, primary rat hepatocyte cultures, exhibiting time-dependent mdr1b overexpression, demonstrated basal COX-2 and COX-1 mRNA expression and liberation of prostaglandin E 2 (PGE 2 ), indicative of an active COX-dependent arachidonic acid metabolism. PGE 2 accumulation in culture supernatants was further enhanced by arachidonic acid (1mol/L) and epidermal growth factor (EGF) (16 nmol/L). PGE 2 and prostaglandin F 2␣ (PGF 2 ␣) (3-6g/mL), added directly to the culture medium, significantly upregulated intrinsic mdr1b mRNA overexpression and mdr1-dependent transport activity. Up-regulation was maximal after 3 days of culture. Like prostaglandins, the COX substrate, arachidonic acid, also induced mdr1b gene expression. Apart from this, structurally different COX inhibitors (indomethacin, meloxicam, NS-398) mediated significant inhibition of time-dependent and EGF-induced mdr1b mRNA overexpression, resulting in enhanced intracellular accumulation of the mdr1 substrate, rhodamine 123 (Rho123). Thus, the present data support the conclusion that the release of prostaglandins through activation of the COX system participates in endogenous mdr1b gene regulation. COX-2 inhibition might constitute a new strategy to counteract primary mdr1-dependent chemotherapy resistance. (HEPATOLOGY 2002;35:579-588.) P -glycoproteins (P-gps) constitute a small subgroup of the large adenosine triphosphate (ATP)-binding cassette transporter superfamily. P-gps encoded by multidrug resistance 2 (mdr2) genes (also termed MDR3 in humans) are thought to function as plasma membrane-located phosphatidylcholine flippases. 1 In contrast, mdr1-type P-gps act as membrane-bound export "pumps" for a wide range of structurally and functionally unrelated hydrophobic xenobiotics, including naturally occurring cytotoxic substrates, as well as several drugs and antineoplastic compounds. The membrane passage of endogenous substrates like some steroid hormones, and perhaps peptides and cytokines, might also be mediated through mdr1 proteins. While only one drug-transporting P-gp has been identified in humans (MDR1), two closely related mdr1 genes (mdr1a and mdr1b) exist in rodents. Mdr1-type P-gps are physiologically expressed in excretory organs like liver or kidney and in tissues with a barrier function, implicating a critical role of mdr1 proteins in the elimination of potentially toxic substrates. Intrinsic or drug-induced overexpression of mdr1-type P-gps, however, is one of the major factors leading to a multidrug resistance phenotype of tumor cells, thus limiting cancer chemotherapy by ATP-dependent extrusion of diverse hydrophobic cytostatics from the cell (reviewed in Gottesman 2 and Johnstone 3 ).
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In the normal liver, mdr1-type P-gps are localized in the canalicular membrane region of hepatocytes, participating in biliary elimination of hydrophobic substrates. 4 Intrinsic up-regulation of mdr1 gene expression has been observed in untreated hepatocellular carcinoma of human and rodent origin, associated with primary resistance to certain antineoplastic compounds, 5, 6 during inflammation-associated processes, e.g., cholestasis, 7, 8 and during liver regeneration. 9 However, hepatic mechanisms and mediators of intrinsic mdr1 gene activation are poorly understood.
Recent studies have demonstrated overexpression of the heme protein, cyclooxygenase-2 (COX-2), in regenerative nodules of cirrhotic livers and in well-differentiated hepatocellular carcinoma 10, 11 -pathophysiologic situations that are also characterized by endogenous overexpression of mdr1-type P-gps. 6, 12, 13 The stress-and cytokine-inducible COX-2 isoform (reviewed in Fosslien 14 ) and the more constitutively expressed COX-1 isoform both catalyze the reactive oxygen species-dependent conversion of arachidonic acid into prostaglandin endohydroperoxides, which are subsequently converted to prostanoids, including prostaglandin E 2 (PGE 2 ) and F 2␣ (PGF 2␣ ). 15 Interestingly, PGE 2 , PGF 2␣ , and prostacyclin play an important role in liver regeneration and hepatocyte proliferation. [16] [17] [18] [19] As a result of parallel up-regulation of mdr1 and COX-2 gene expression during pathophysiologic changes in liver integrity, we hypothesized that an activation of the COX system might be a critical event in the development of a primary mdr1-mediated drug resistance.
In previous studies, primary rat hepatocyte cultures served as a model to investigate endogenous mechanisms of mdr1b gene regulation in the rat liver. Rat hepatocyte cultures are characterized by a basal, time-dependent mdr1b overexpression, 20, 21 resembling mdr1b gene activation in early stages of hepatocarcinogenesis or during liver regeneration. Using this model system, it was demonstrated that mdr1b mRNA and functional mdr1-type P-gp expression are induced by treatment with epidermal growth factor (EGF), 20 insulin-like growth factor-I, 20 tumor necrosis factor ␣ (TNF-␣), 22 transforming growth factor ␤, or by reactive oxygen species, e.g., H 2 O 2 , 23 stimuli also known to enhance COX-2 expression in several cell types. 14, 24, 25 On the other hand, basal mdr1b overexpression of the cells is down-regulated by glucocorticoids 26 and antioxidants, 23 mediators known to inhibit COX-2 expression and subsequent prostaglandin synthesis. 14 In the present study, PGE 2 and PGF 2␣ , the COX substrate arachidonic acid, and structurally differing COX inhibitors were thus used to define a role of the COX system in mdr1b gene regulation.
Materials and Methods
Animals and Materials. Rat hepatocytes were isolated from adult male Wistar rats (180-240 g). All chemicals used were of reagent-grade quality. Collagenase CLS ⌱⌱ was from Biochrom (Berlin, Germany), fetal calf serum was from PAA (Coelbe, Germany), and collagen type ⌱ was purchased from Becton Dickinson (Heidelberg, Germany). EGF and T4 polynucleotide kinase were from Roche Molecular Biochemicals (Mannheim, Germany). Insulin, hydrocortisone hemisuccinate, arachidonic acid, and other biochemicals were obtained from Sigma (Deisenhofen, Germany). PGE 2 , PGF 2␣ , NS-398, and indomethacin were purchased from Calbiochem (Bad Soden, Germany). Meloxicam was a generous gift from Boehringer (Ingelheim, Germany).
Cell Isolation and Culture. Primary rat hepatocytes were isolated by in situ collagenase perfusion as described previously. 20 Hepatocyte suspensions showed viabilities Ͼ90% as determined by Trypan blue exclusion. Cells were suspended in MX-82 medium 27 containing 10% fetal calf serum and plated at a density of 8.6 ϫ 10 4 cells/cm 2 on culture dishes (Nunc, Roskilde, Denmark), precoated with collagen type ⌱ (4.1g/cm 2 ). Following an initial attachment period of 3 hours at 37°C in a humidified atmosphere of 10% CO 2 and 90% air, the medium was replaced with serumfree MX-83 medium, 27 lacking arginine, but supplemented with 1mol/L insulin and 20mol/L hydrocortisone hemisuccinate. Hepatocytes were cultured for up to 5 days. Media changes were performed daily. In designated experiments, the medium contained prostaglandins, arachidonic acid, EGF, or COX inhibitors, as indicated. Prostaglandins and arachidonic acid were predissolved in ethanol, COX inhibitors in dimethylsulfoxide, and were each diluted to desired concentrations with MX-83 medium.
One-step Reverse-Transcription Polymerase Chain Reaction. COX-1 and COX-2 mRNAs were detected by employing the SuperScript One-step reverse-transcription polymerase chain reaction (RT-PCR) kit (Gibco BRL Life Technologies, Karlsruhe, Germany). Total RNA was isolated from cultured rat hepatocytes as described below. One-step RT-PCR was performed in an Eppendorf Mastercycler gradient (Eppendorf, Hamburg, Germany). Primers were used at 500 nmol/L each and were as follows: rat COX-1 sense (5Ј-TTTGCACAACACTTCACCCACCAG-3Ј) and antisense (5Ј-AAACACCTCCTGGCCCACAGCCAT-3Ј); rat COX-2 sense (5Ј-CTTCGGGAGCACAACAGAGT-3Ј) and antisense (5Ј-CCAGCAGGGCGGGATACAGT-3Ј). The respective primer pair and 1g of total RNA were denatured (10 minutes, 70°C), reaction buffer and the reverse-transcriptase/Taq polymerase mix were added, and reverse transcription was performed (45 minutes, 45°C). Subsequent to inactivation of the reverse transcriptase (2 minutes, 94°C), the samples were subjected to 35 amplification cycles, each consisting of 20 seconds at 96°C, 1 minute at 63°C, and 1 minute at 72°C, followed by 7 minutes at 72°C after the last cycle. The PCR products were analyzed on a 1% agarose gel and visualized by ethidium bromide staining. Molecular weights of the amplification products were calculated by a 1-kb standard DNA ladder (Gibco BRL Life Technologies). The COX-1 primer set yielded a 275-bp; the COX-2 primer set yielded a 609-bp PCR product.
Quantification of PGE 2 . PGE 2 was detected in culture supernatants of primary rat hepatocyte cultures by a highly sensitive and specific competitive enzyme immunoassay, using a monoclonal antibody from clone E2R1. 28 Rat hepatocytes were precultured for 2 days on 21.5-cm 2 dishes. The medium was then replaced with 2 mL of fresh MX-83 medium with or without addition of arachidonic acid, EGF, or meloxicam. One to 24 hours later, culture supernatants and cells were frozen in liquid nitrogen and stored at Ϫ80°C. PGE 2 concentration in the culture supernatants was subsequently determined, diluting standard and samples in RPMI-1640. The detection limit for PGE 2 was 3 pg per well of a 96-well microculture plate. Results were calculated from the standard curve using a cubic spline interpolation. Data were normalized for the relative protein content per culture dish, setting protein content of the control values after 24 hours of incubation to 100%.
RNA Isolation and Northern Blot Analysis. Total cellular RNA was isolated by guanidinium thiocyanate-phenol-chloroform extraction as described previously. 23 For Northern blots, 25g of total RNA per lane was separated electrophoretically through 1% formaldehyde/agarose gels. RNA was subsequently blotted onto Hybond N nylon membranes (Amersham Pharmacia Biotech, Braunschweig, Germany) by capillary transfer using 20ϫ SSC (3 mol/L NaCl, 0.3 mol/L trisodium citrate) as the transfer buffer. Blots were hybridized to oligonucleotides specific for the rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (5Ј-CAG-GATGCATTGCTGACAATCTTGA-3Ј), mdr1b, 20 or mdr2 gene. 22 The oligonucleotides had been 5Ј-end-labeled with T4 polynucleotide kinase using [␥-32 P]ATP (Amersham Pharmacia Biotech). The blots were prehybridized for 3 hours and hybridized for 16 hours at 38°C, as described previously. 23 They were then washed up to a stringency of 1ϫ SSC/0.1% sodium dodecyl sulfate (SDS) (wt/vol) (mdr1b, mdr2, COX-2) or 0.1ϫ SSC/0.1% SDS (GAPDH) at 38°C, respectively. The expression of specific mRNAs was quantified by a BAS 1500 Bio-Imaging Analyzer (Fujix, Tokyo, Japan).
Immunoblot Analysis of P-gps. Subcellular hepatocyte fractions were enriched for plasma membranes by sucrose gradient centrifugation as described previously. 23 The buffers used for homogenization and centrifugation contained 1 mmol/L phenylmethylsulfonyl fluoride. Aliquots of 10g of protein per lane were separated electrophoretically through 7.5% SDS-polyacrylamide gels. Membrane proteins were subsequently transferred to polyvinylidene difluoride membranes (Millipore, Eschborn, Germany) by semidry blotting, using a continuous buffer system (48 mmol/L Tris, 39 mmol/L glycine, 0.038% [wt/vol] SDS, and 15% [vol/ vol] methanol, pH 9.0). P-gps were detected by using the primary polyclonal anti-Pgp antibody, PC03 (Oncogene Research Products, Cambridge, MA), directed against a protein region conserved in all rat P-gps. A secondary peroxidase-coupled anti-rabbit IgG antibody (Sigma) was used in combination with the enhanced chemiluminescence detection kit (Amersham Pharmacia Biotech) to visualize the immunoreactive protein.
Determination of Intracellular Rhodamine 123 Accumulation. Rat hepatocytes, precultured for 3 days on 21.5-cm 2 dishes under the indicated culture conditions, were incubated for 3 hours with MX-83 medium containing 6.5mol/L of the fluorescent mdr1 substrate, rhodamine 123 (Rho123), in the presence or absence of 10mol/L (Ϯ) verapamil, a known inhibitor of mdr1-dependent transport activity. Subsequently, the adherent cells were washed 5 times with ice-cold phosphate-buffered saline, and the dye was extracted by incubation with 2.5 mL n-butanol per dish for 10 minutes at room temperature. Rho123 concentrations were measured fluorometrically in the butanol extracts as described previously. 23 Data were normalized for protein content per culture dish.
Results
Expression of Functionally Active COX Enzymes in Primary Rat Hepatocyte Cultures. We hypothesized that the COX system might participate in spontaneous, time-dependent mdr1b overexpression that is observed in primary rat hepatocyte cultures. 20, 21 Employing one-step RT-PCR, we detected basal COX-2 as well as COX-1 mRNA expression in rat hepatocytes cultured for 3 days (Fig. 1) . COX mRNA expression reflected functionally active COX protein expression, because PGE 2 accumulated in culture supernatants in a time-dependent manner ( Fig.  2A) . PGE 2 liberation was further stimulated by treatment of cells with 1mol/L arachidonic acid, amounting to a ϳ3.6-fold increase after 1 hour and a ϳ2.5-fold increase after 24 hours of incubation, as compared with controls ( Fig. 2A) . In the presently applied culture system, primary rat hepatocytes thus demonstrated intrinsic expression of functionally active COX enzymes. Interestingly, cells cultured for up to 5 days in the presence of 1mol/L arachidonic acid demonstrated enhanced mdr1b mRNA expression (Fig. 2B ). Up-regulation was already evident after 1 day in culture but was maximal after 3 days, amounting to mean mdr1b mRNA levels of 166% Ϯ 3.8% (n ϭ 4) of related controls. Arachidonic acid thus mediated stimulation of PGE 2 synthesis as well as induction of mdr1b mRNA overexpression.
Prostaglandins as Mediators of Time-Dependent mdr1b Up-regulation. Prostaglandins have been shown to exert different physiologic as well as pathophysiologic functions in liver tissue. In the present study, rat hepatocyte cultures, characterized by a basal, time-dependent mdr1b overexpression (Figs. 2B and 3A), generated significant amounts of PGE 2 ( Fig. 2A) . To test whether PGE 2 might serve as a mediator for endogenous mdr1b up-regulation, cells were cultured in the absence or presence of 1 to 6 g/mL PGE 2 for up to 4 days. Indeed, PGE 2 mediated time- (Fig. 3A) and concentration-dependent (Fig. 3B ) induction of mdr1b mRNA expression. A significant, 1.6-fold increase in mdr1b mRNA levels was observed at 3 g/mL PGE 2 after 3 days in culture ( Fig. 3A and  3B ). Higher PGE 2 concentrations (6 g/mL) resulted in ϳ3-fold enhanced expression levels, as compared with control hepatocytes (Fig. 3B) . On the other hand, mdr2 and GAPDH mRNA expression remained uninfluenced by PGE 2 treatment (Fig. 3B) , indicating a gene-and isoform-specific effect. Similar induction of mdr1b mRNA expression was obtained with PGF 2␣ , another product of the COX-dependent arachidonic acid metabolism (data not shown).
To further investigate the functional relevance of the prostaglandin-dependent mdr1b mRNA up-regulation for the mdr1-dependent transport capacity of treated cells, Rho123-accumulation assays were performed. Accumulation of high intracellular Rho123 Fig. 1 . COX-1 and COX-2 mRNA expression in primary rat hepatocyte cultures. Total RNA was extracted from control cultures 3 days after cell seeding. COX-1 and COX-2 mRNAs were reversely transcribed and cDNA was amplified by one-step RT-PCR as described in Materials and Methods. For analysis, 25L of each PCR product was run on a 1% agarose gel. Lane 1, 1-kb DNA ladder; lane 2, PCR product of COX-1 primer set; lane 3, PCR product of COX-2 primer set.
levels are indicative of a low mdr1-dependent transport activity and vice versa. After 3 days in culture, PGE 2 - (Fig. 3C) and PGF 2␣ -(data not shown) pretreated cells accumulated significantly less Rho123 over an incubation period of 3 hours, compared with controls (3 g/mL PGE 2 : 71% Ϯ 3.7%; 3 g/mL PGF 2␣ : 67.8% Ϯ 2.4%). The decrease in Rho123 retention under PGE 2 was almost completely reversed by co-incubation with dye and 10 mol/L (Ϯ) verapamil, a calcium channel blocker that is also a well-known inhibitor of mdr1-dependent transport activity (Fig.  3C ). Rat hepatocytes, precultured without PGE 2 and then exposed to Rho123 in the presence of PGE 2 , retained equal amounts of dye as compared with control cells incubated with dye alone. Thus, the possibility that PGE 2 might directly affect mdr1-dependent transport could be excluded (data not shown). Rho123-accumulation studies consequently demonstrated that prostaglandin-mediated induction of mdr1b mRNA expression resulted in an overexpression of functionally active mdr1-type P-gp(s).
COX Inhibitors as Modulators of Basal mdr1b
Overexpression and Function. If the COX-dependent liberation of prostaglandins in the liver might participate in endogenous mdr1b upregulation observed during cholestasis, liver regeneration, or hepatocarcinogenesis, nonsteroidal anti-inflammatory drugs (NSAIDs) acting as COX inhibitors would be expected to inhibit intrinsic mdr1b overexpression of primary rat hepatocyte cultures. We first performed prostaglandin-liberation experiments with the therapeutically used, COX-2-preferential inhibitor, meloxicam, to assess concentrations that significantly inhibited PGE 2 generation in our culture system. As compared with control cultures, cells treated with 100 nmol/L or 10 mol/L meloxicam generated considerably less PGE 2 during a 24-hour incubation period, with the concentration of 10 mol/L meloxicam being most effective (Fig. 4A) .
In parallel, rat hepatocytes cultured for up to 3 days in the presence of 10 mol/L meloxicam indeed demonstrated downregulation of basal mdr1b mRNA overexpression (Fig. 4B) . After 3 days in culture, mean mdr1b mRNA levels decreased to 65% Ϯ 7.5% (n ϭ 3) of controls. Intrinsic mdr1b mRNA overexpression of rat hepatocyte cultures was also concentration-dependently down-regulated by indomethacin, a general inhibitor of the COX enzymatic function (Fig. 5) . As compared with controls, cells treated for 3 days with 100 mol/L indomethacin demonstrated reduced mean mdr1b mRNA levels of 45% Ϯ 2.1% (n ϭ 3), respectively. In contrast, GAPDH mRNA expression remained unaffected in the presence of meloxicam (Fig. 4B) or indomethacin (Fig. 5) , indicating a specific down-regulation of basal mdr1b mRNA overexpression by these NSAIDs. As compared with controls, hepatocytes precultured for 3 days with meloxicam (Fig. 4C ) or indomethacin (data not shown) demonstrated enhanced intracellular dye levels in Rho123-accumulation assays, pointing to reduced mdr1-dependent transport activity. In the meloxicam concentration range tested, this effect was maximal at 10 mol/L meloxicam with ϳ2-fold higher intracellular Rho123 concentrations (Fig. 4C) . Interestingly, indomethacin has been identified as a direct transport inhibitor of multidrug resistance-associated proteins (MRP). 29 Nevertheless, any direct inhibition of pre-existing mdr1-type proteins by indomethacin, meloxicam, or other COX inhibitors could be ruled out by concomitant incubation of cultures with Rho123 and the respective COX inhibitor during Rho123-accumulation studies (data not shown). The increase in Rho123 accumulation in cells precultured in the presence of COX inhibitors thus most likely reflected down-regulation of functionally active mdr1-type P-gp(s).
Down-regulation of Basal mdr1b mRNA and P-gp Overexpression by the COX-2-Selective Inhibitor, NS-398. To differentiate between the two COX isoforms (COX-1 and COX-2), concerning the postulated role of the COX system in induction of endogenous mdr1b overexpression, we used NS-398, a compound that is employed as an experimental tool to specifically inhibit the COX-2 enzyme. 30 In our culture system, treatment of cells with NS-398 led to a concentration-dependent decrease in basal mdr1b mRNA overexpression after 3 days in culture. Maximal, highly Total RNA was isolated from primary rat hepatocytes, cultured for up to 5 days on plastic dishes in the presence or absence of 1mol/L arachidonic acid. The blot was hybridized to a mdr1b-specific oligonucleotide probe. Equal gel loading was confirmed by ethidium bromide staining of 18S and 28S rRNA.
significant inhibition could already be demonstrated at a concentration of 10 nmol/L NS-398, with mean mdr1b mRNA levels of 37% Ϯ 21.6% of control cultures (Fig. 6) . Interestingly, NS-398 concentrations of more than 100 nmol/L were less effective. Western blot analyses with a polyclonal anti-P-gp antibody revealed inhibition of time-dependent P-gp overexpression by treatment of rat hepatocyte cultures with 1mol/L NS-398 for 3 days (Fig. 7A) . Parallel Rho123-accumulation studies with NS-398 -pretreated cells demonstrated an increase in dye accumulation, pointing to a decrease in mdr1-dependent transport capacity (Fig. 7B) . In conclusion, these data suggest that the COX-2 enzyme might play an important role in endogenous mdr1b gene regulation.
Effect of NS-398 on EGF-Induced mdr1b Overexpression in Primary Rat Hepatocyte Cultures. We previously demonstrated that the hepatotrophic growth factor, EGF, induces functionally active mdr1b overexpression in primary rat hepatocyte cultures. 20 Recent studies now have pointed to an EGF-mediated stimulation of PGE 2 generation in hepatocytes and other cell types, which was mainly the result of enhanced cytosolic phospholipase A 2 activity 31 and COX-2 expression. 31, 32 We thus speculated whether an induction of the COX system might be one critical step in the signaltransduction pathway leading to EGF-dependent up-regulation of mdr1b expression. In our culture system, rat hepatocytes, incubated for 24 hours with 16 nmol/L EGF, liberated significantly more PGE 2 than untreated cells, amounting to a ϳ2.3-fold increase (Fig. 7C) , respectively. Northern blot analyses with a COX-2-specific oligonucleotide probe revealed that an enhanced COX-2 mRNA expression might participate in EGF-mediated increase in PGE 2 generation (data not shown).
To directly investigate whether the COX system might be involved in EGF-dependent mdr1b induction, primary rat hepatocytes were precultured for 3 days with or without 16 nmol/L EGF, 1mol/L NS-398, or both. Subsequent Western blot analyses and Rho123-accumulation assays demonstrated that the EGF-induced increase in functionally active P-gp overexpression ( Fig. 7A and 7B) could completely be prevented by co-treatment of cells with 1mol/L NS-398. EGF-induced mdr1b mRNA overexpression was also inhibited by NS-398 (data not shown). Thus, the COX system, particularly the COX-2 isoform, might be a key enzyme in the signal-transduction pathway involved in EGF-dependent regulation of the mdr1b gene.
Discussion
Mdr1-type P-gps participate in the distribution and/or elimination of a wide range of therapeutic agents. In particular, many 4™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™ Fig. 3 . Enhancement of time-dependent mdr1b mRNA overexpression and decrease in Rho123 accumulation in PGE 2 -pretreated rat hepatocyte cultures. Cells were cultured for up to 4 days in the absence or presence of 1 to 6 g/mL PGE 2, as indicated. (A) Mdr1b mRNA expression. Expression was determined by hybridization to a mdr1b-specific oligonucleotide probe. Basal mdr1b mRNA expression after 3 days was set to 100%. Data represent mean values Ϯ SE of 4 (0, freshly isolated hepatocytes), 6 (1 day), 7 (2 days), 9 (3 days), or 3 (4 days) independent experiments. Significantly different from control values: ***P Յ .001; Student t test for paired values. (B) Representative Northern blot. The membrane was hybridized to a mdr1b-specific probe and rehybridized to oligonucleotides specific for mdr2 and GAPDH mRNA. (C) Rho123-accumulation assay. After 3 days in culture, control and PGE 2 -pretreated rat hepatocytes were incubated for 3 hours in MX-83 medium, containing 6.5 mol/L Rho123 with or without 10 mol/L verapamil. Control values (0) were set to 100%. Data are expressed as mean levels Ϯ SD of a representative experiment performed in triplicate. Significantly different from control, ***P Յ .001; Student t test for unpaired values.
antineoplastic compounds are known to be subject to mdr1-dependent extrusion. To develop new therapeutic concepts for counteracting primary mdr1-dependent chemotherapy resistance of tumor cells, and to better understand variabilities in drug elimination, it is of great importance to clarify the physiologic regulation of mdr1-type P-gp expression. From this point of view, it is of special interest whether structurally and functionally differing mdr1-inducing stimuli share common signal-transduction pathways.
A recent publication pointed to an important role of heme proteins in oxygen-dependent mdr1b gene regulation. 33 Interestingly, a broad spectrum of diverse mdr1-inducing stimuli like UV irradiation, 34 H 2 O 2 , 23 or several cytokines 20, 22 are also known to trigger the expression of the heme-dependent COX-2 enzyme with the subsequent liberation of prostanoids. 14, 24, 25 In the present study, treatment of primary rat hepatocyte cultures with the prostaglandins, PGE 2 and PGF 2␣ , or with the COX substrate, arachidonic acid significantly up-regulated intrinsic mdr1b mRNA overexpression, observed with time in culture. On the other hand, structurally differing COX inhibitors (indomethacin, meloxicam, NS-398) all led to a significant, dose-dependent reduction in functional mdr1b expression, suggesting an important role of the COX system in endogenous mdr1b gene regulation.
Because the prostanoids, PGE 2 and PGF 2␣ , time-and dosedependently increased functional mdr1b overexpression in our culture system, prostaglandins might also constitute endogenous mediators of COX-dependent mdr1 gene activation in vivo. In the liver, prostaglandin synthesis seems to be altered in the course of several pathophysiologic situations like hepatocarcinogenesis, 10, 11 liver regeneration, 19 and cirrhosis, 10 during which mdr1 expression is also up-regulated. 5, 6, 9, 12, 13 Which prostaglandin receptor subtypes are involved in prostaglandin-dependent mdr1b up-regulation remains to be determined. PGE 2 , for instance, exerts its Fig. 5 . Indomethacin-mediated inhibition of basal mdr1b mRNA overexpression in primary rat hepatocyte cultures. Representative Northern blot. Total RNA was extracted from rat hepatocytes precultured for 3 days in the absence or presence of 1 to 100 mol/L indomethacin. The membrane was hybridized to a mdr1b-specific probe and further reprobed with a GAPDHspecific oligonucleotide. versatile actions through the specific cell-surface prostaglandin E receptors, EP 1 -EP 4 (for the rat, see Boie 35 ). EP 1 -EP 4 belong to the family of G protein-coupled receptors, initiating different signaltransduction pathways, which involve type 1 cyclic adenosine monophosphate (cAMP)-dependent protein kinase A or phosphoinositide-specific phospholipase C. 36 Interestingly, a direct role of cAMP-dependent protein kinase A in the regulation of the human MDR1 gene has been defined previously (Wartenberg 37 and reference therein).
Intrinsic mdr1b overexpression observed in rat hepatocyte cultures, 33, 38 as well as the up-regulation of the rat mdr1b gene by different stimuli like reactive oxygen species 39, 40 or cytotoxic drugs, 41 has been characterized to be primarily the result of enhanced transcription. Preliminary studies with an mdr1b promoter/luciferase gene construct have demonstrated that prostaglandin-dependent mdr1b induction also occurs at the transcriptional level (Ziemann et al., unpublished data, June 2001) . The rat mdr1b gene promoter (GenBank Accession Numbers L16546 and AJ312410) contains several cis-regulatory elements for cAMP-regulated transcription factors, including activator protein 1-and SP1-binding sites as well as a cAMP-responsive element. 42, 43 Furthermore, regulatory elements for nuclear factor-B (NF-B) and p53 have been identified. The multisubunit transcription factor, NF-B, seems to be essential for basal (Zhou 41 and reference therein), TNF-␣-mediated, 38 and reactive oxygen species-mediated 40 activation of the rat mdr1b gene. Interestingly, stimulation of the porcine EP3 receptor led to subsequent translocation of NF-B into the nuclear compartment. 44 Because EP3 receptor subtypes are constitutively expressed in the rat liver, 35 modulation of an NF-B-dependent signal transduction pathway might be responsible for induction of mdr1b gene expression by PGE 2 and PGF 2␣ in primary rat hepatocyte cultures. The observed induction of mdr1b mRNA expression by prostaglandins and arachidonic acid supports the conclusion that the inhibition of mdr1b mRNA expression by COX inhibitors is the result of direct repression of prostaglandin synthesis. Nevertheless, further studies are necessary to exclude that NSAID-mediated, direct blocking of transcription factor activation (e.g., NF-B and activator protein 1), which has been observed for some anti-inflammatory drugs, e.g., glucocorticoids, salicylic acid derivatives, flurbiprofen, or ibuprofen also participates in mdr1b down-regulation. 45 Because the COX-2-specific inhibitor, NS-398, even at a 10-nmol/L concentration, was also effective in inhibiting time-dependent mdr1b overexpression in rat hepatocyte cultures, COX-2 rather than COX-1 might be the isoform predominantly involved in mdr1b induction. Previous studies indeed demonstrated basal expression 49 and inducibility of the COX-2 gene in primary rat hepatocyte cultures, for instance by dioxin 49 or lipopolysaccharide. 50 In the present study, cultured rat hepatocytes also exhibited basal COX-2 mRNA expression, which was further up-regulated by EGF (Ziemann et al., unpublished data, March 2000), known to stimulate in parallel functionally active mdr1b overexpression. 20 Induction of the COX system by EGF with subsequent liberation of prostaglandins seems to be involved in signal transduction, leading to EGF receptor-stimulated proliferation of rat hepatocytes in vitro. 16, 18 EGF has previously been demonstrated to specifically up-regulate COX-2 expression and function in human squamous carcinoma A431 and in amnion-derived WISH cells, without affecting COX-1 expression. 31, 32 Because the EGF-mediated P-gp induction, observed in this study, was completely reversed by coincubation with NS-398 (Fig. 7) , one can conclude that COX-2 plays a pivotal role in basal as well as EGF-dependent mdr1b overexpression.
Interestingly, the inhibitory effect of the reversible COX-2 inhibitor, NS-398, on basal mdr1b mRNA overexpression in our culture system was biphasic, with concentrations higher than 10 to 100 nmol/L being less effective. This observation is in line with a recent study, demonstrating a loss of anti-inflammatory efficacy of the COX-2-selective inhibitor, celecoxib, at high doses through paradoxical activation of NF-B and the subsequent induction of NF-B-dependent proinflammatory genes like COX-2 itself or TNF-␣. 46 Because the rat mdr1b gene has been shown to be regulated in a NF-B-dependent manner, 38, 40, 41 induction of the mdr1b gene through activation of NF-B could also account for the paradoxical effect of NS-398 in our culture system. In addition, Callejas et al. observed COX-2 protein accumulation in the presence of lipopolysaccharide in fetal rat hepatocyte cultures treated with high NS-398 doses (50-500 mol/L). 47 Besides, employing the J774.2 monocyte/macrophage cell line and high, apoptosisinducing concentrations of diclofenac (Ͼ100 mol/L) or indomethacin (500 mol/L), Simmons et al. postulated the induction of a COX-2 variant with reduced NSAID sensitivity or a third COX isoform by prolonged NSAID treatment, 48 which might also be responsible for the lack of repression of mdr1b mRNA expression by excessive NS-398 treatment in our system. In summary, the present study reveals that the COX (in particular, the COX-2)-dependent liberation of prostaglandins is involved in basal as well as EGF-induced mdr1b gene expression in primary rat hepatocyte cultures. It appears likely that prostaglandins also participate in the regulation of mdr1 expression during pathophysiologic changes in liver integrity, which are associated with COX-2 up-regulation. Further studies are required to clarify whether NSAID treatment might alter drug distribution and/or elimination in vivo as a result of down-regulation of mdr1-type P-gps in excretory organs like liver or bowel. In addition, it remains to be elucidated whether COX-2 inhibition might constitute an effective strategy to counteract primary mdr1-dependent chemotherapy resistance.
